Regeneron Pharmaceuticals Inc
LSE:0R2M
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regeneron Pharmaceuticals Inc
LSE:0R2M
|
US |
|
C
|
Carlsberg A/S
F:CBGA
|
DK |
|
C
|
China Northern Rare Earth (Group) High-Tech Co Ltd
SSE:600111
|
CN |
|
Coca-Cola HBC AG
LSE:CCH
|
CH |
|
Kulicke and Soffa Industries Inc
NASDAQ:KLIC
|
SG |
|
Italgas SpA
OTC:ITGGF
|
IT |
|
CGN Power Co Ltd
SZSE:003816
|
CN |
|
U
|
US Bancorp
XETRA:UB5
|
US |
|
Penguin International Ltd
SGX:BTM
|
SG |
|
E
|
Eaton Corporation PLC
LSE:0Y3K
|
IE |
|
Titomic Ltd
ASX:TTT
|
AU |
|
C
|
Cogobuy Group
F:7C3
|
CN |
|
N
|
Nsys Co Ltd
KOSDAQ:333620
|
KR |
|
Airbus SE
PAR:AIR
|
NL |
|
L
|
Land Securities Group PLC
OTC:LSGOF
|
UK |
|
M
|
Mosaic Co
SWB:02M
|
US |
|
Baosheng Media Group Holdings Ltd
NASDAQ:BAOS
|
CN |
|
C
|
CrowdStrike Holdings Inc
LSE:0A3N
|
US |
|
Relo Group Inc
OTC:RELOF
|
JP |
|
R
|
Ross Stores Inc
BMV:ROST
|
US |
|
U
|
Uni-President China Holdings Ltd
SWB:58U
|
CN |
|
CrowdStrike Holdings Inc
BMV:CRWD
|
US |
|
Mosaic Co
NYSE:MOS
|
US |
|
MTU Aero Engines AG
F:MTX1
|
DE |
Bankruptcy Probability
Regeneron Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Regeneron Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
96.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
362.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
137.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
129B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
70.6T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
509.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
208B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
96.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Regeneron Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Regeneron Pharmaceuticals Inc has total debt of 2B USD. This includes both short-term (0 USD) and long-term (2B USD) debt.
You can find a full breakdown on its Balance Sheet.
